Skip to content
← Back to this collection

PUBLICATIONS · 30674657

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Sci Transl Med
Publication date
2019 Jan 23
First author
Pascual-Pasto G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Pascual-Pasto G
      type
      Author
    2. name
      Bazan-Peregrino M
      type
      Author
    3. name
      Olaciregui NG
      type
      Author
    4. name
      Restrepo-Perdomo CA
      type
      Author
    5. name
      Mato-Berciano A
      type
      Author
    6. name
      Ottaviani D
      type
      Author
    7. name
      Weber K
      type
      Author
    8. name
      Correa G
      type
      Author
    9. name
      Paco S
      type
      Author
    10. name
      Vila-Ubach M
      type
      Author
    11. name
      Cuadrado-Vilanova M
      type
      Author
    12. name
      Castillo-Ecija H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Pascual-Pasto G
      type
      Author
    2. name
      Bazan-Peregrino M
      type
      Author
    3. name
      Olaciregui NG
      type
      Author
    4. name
      Restrepo-Perdomo CA
      type
      Author
    5. name
      Mato-Berciano A
      type
      Author
    6. name
      Ottaviani D
      type
      Author
    7. name
      Weber K
      type
      Author
    8. name
      Correa G
      type
      Author
    9. name
      Paco S
      type
      Author
    10. name
      Vila-Ubach M
      type
      Author
    11. name
      Cuadrado-Vilanova M
      type
      Author
    12. name
      Castillo-Ecija H
      type
      Author
    bibliography ids
    1. nci-bib-0836619c84b87244babaf48e
    book metadata
    content sha256
    3a75d3dbe08ac2a027b042a41549848e6e22a86f1c26972534410cd7331c9d0b
    document type
    citation
    dois
    1. 10.1126/scitranslmed.aat9321
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30674657
    immutable id
    pubmed:30674657@3a75d3dbe08ac2a027b042a41549848e6e22a86f1c26972534410cd7331c9d0b
    journal
    abbreviation
    Sci Transl Med
    issn electronic
    1946-6242
    issn print
    1946-6234
    issue
    476
    name
    Science translational medicine
    nlm unique id
    101505086
    pages
    Source null
    volume
    11
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30674657
      provenance
      batch id
      e808962322f3afebc564
      provider
      NCBI PubMed ESummary
      record sha256
      38af3e169cfad90a536770df372addfbb9088a2e3219498fc8842c57966f075c
      response sha256
      3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
      retrieved at
      2026-09-09T23:47:41.002093+00:00
      publication date
      display
      2019 Jan 23
      precision
      day
      year
      2019
      publication types
      1. Clinical Trial, Phase I
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30674657/
      title
      Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01.

      Preserved source evidence · Not medical advice